Kraig Biocraft Financials
| KBLB Stock | USD 0.1 0 1.20% |
With this module, you can analyze Kraig financials for your investing period. You should be able to track the changes in Kraig Biocraft individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Kraig |
Understanding current and past Kraig Biocraft Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Kraig Biocraft's financial statements are interrelated, with each one affecting the others. For example, an increase in Kraig Biocraft's assets may result in an increase in income on the income statement.
The data published in Kraig Biocraft's official financial statements usually reflect Kraig Biocraft's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Kraig Biocraft Labs. For example, before you start analyzing numbers published by Kraig accountants, it's critical to develop an understanding of what Kraig Biocraft's liquidity, profitability, and earnings quality are in the context of the Chemicals space in which it operates.
Please note, the presentation of Kraig Biocraft's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kraig Biocraft's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Kraig Biocraft's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Kraig Biocraft Labs. Please utilize our Beneish M Score to check the likelihood of Kraig Biocraft's management manipulating its earnings.
Kraig Biocraft Stock Summary
Kraig Biocraft competes with Covalon Technologies, Mosaic Immunoengineerin, and Cellectis. Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. Kraig Biocraft operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 38 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US50075W1045 |
| Business Address | 2723 South State |
| Sector | Chemicals |
| Industry | Materials |
| Benchmark | NYSE Composite |
| Website | www.kraiglabs.com |
| Phone | 734 619 8066 |
| Currency | USD - US Dollar |
You should never invest in Kraig Biocraft without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Kraig OTC Stock, because this is throwing your money away. Analyzing the key information contained in Kraig Biocraft's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Kraig Biocraft Key Financial Ratios
Generally speaking, Kraig Biocraft's financial ratios allow both analysts and investors to convert raw data from Kraig Biocraft's financial statements into concise, actionable information that can be used to evaluate the performance of Kraig Biocraft over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Kraig Biocraft Labs reports annually and quarterly.Kraig Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kraig Biocraft's current stock value. Our valuation model uses many indicators to compare Kraig Biocraft value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kraig Biocraft competition to find correlations between indicators driving Kraig Biocraft's intrinsic value. More Info.Kraig Biocraft Labs is currently regarded as number one stock in return on asset category among related companies. It is considered the number one company in current valuation category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kraig Biocraft by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kraig Biocraft's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kraig Biocraft's earnings, one of the primary drivers of an investment's value.Kraig Biocraft Labs Systematic Risk
Kraig Biocraft's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kraig Biocraft volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Kraig Biocraft Labs correlated with the market. If Beta is less than 0 Kraig Biocraft generally moves in the opposite direction as compared to the market. If Kraig Biocraft Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kraig Biocraft Labs is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kraig Biocraft is generally in the same direction as the market. If Beta > 1 Kraig Biocraft moves generally in the same direction as, but more than the movement of the benchmark.
About Kraig Biocraft Financials
What exactly are Kraig Biocraft Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Kraig Biocraft's income statement, its balance sheet, and the statement of cash flows. Potential Kraig Biocraft investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Kraig Biocraft investors may use each financial statement separately, they are all related. The changes in Kraig Biocraft's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kraig Biocraft's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Kraig Biocraft Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Kraig Biocraft is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Kraig has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Kraig Biocraft's financials are consistent with your investment objective using the following steps:- Review Kraig Biocraft's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Kraig Biocraft's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Kraig Biocraft's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Kraig Biocraft's stock is overvalued or undervalued.
Kraig Biocraft April 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Kraig Biocraft help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kraig Biocraft Labs. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kraig Biocraft Labs based on widely used predictive technical indicators. In general, we focus on analyzing Kraig OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kraig Biocraft's daily price indicators and compare them against related drivers.
| Downside Deviation | 16.07 | |||
| Information Ratio | 0.1703 | |||
| Maximum Drawdown | 45.0 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 25.0 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kraig Biocraft Labs. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Kraig OTC Stock analysis
When running Kraig Biocraft's price analysis, check to measure Kraig Biocraft's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kraig Biocraft is operating at the current time. Most of Kraig Biocraft's value examination focuses on studying past and present price action to predict the probability of Kraig Biocraft's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kraig Biocraft's price. Additionally, you may evaluate how the addition of Kraig Biocraft to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |